J&J's S.M.A.R.T. Stent Journal Ad Implies Off-Label Use - FDA Says
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson Cordis' placement of an advertisement for its S.M.A.R.T. biliary stent in the February, 1999 issue of the journal Endovascular Surgery, prompted an April 28 FDA warning letter.